Guardant Health AMEA wins Oncology Product Innovation of the Year award conferred by Healthcare Medtech Asia Awards
Home » Guardant Health AMEA wins Oncology Product Innovation of the Year award conferred by Healthcare Medtech Asia Awards

GH AMEA in the NewsGuardant Health AMEA wins Oncology Product Innovation of the Year award conferred by Healthcare Medtech Asia Awards
Guardant Health AMEA wins Oncology Product Innovation of the Year award conferred by Healthcare Medtech Asia Awards
Guardant Health AMEA wins Oncology Product Innovation of the Year award conferred by Healthcare Medtech Asia Awards
GH AMEA

Guardant Health AMEA has won the Oncology Product Innovation of the Year in the Healthcare Asia Medtech Awards 2023. Guardant Health is the only precision oncology company with cutting edge diagnostics for advanced cancer, recurrence monitoring of cancer and early detection of cancer. These technologies can help to bend mortality curves and cost curves of cancer globally.

Recognizing trailblazing initiatives in Asia’s healthcare sector, this awards ceremony aims to recognise medtech companies and healthcare industry professionals who have pushed the boundaries to innovate breakthrough products, solutions and initiatives to better serve patients in Asia.

Visit us at https://lnkd.in/gHNdYtQN to find out more about our comprehensive genomic profiling tests which can help guide treatment decisions for patients with cancer.

#guardanthealth #guardanthealthamea #HealthcareAsiaAwards #blazeatrail #awards #precisiononcology #innovation #HealthcareAsiaMedtechAwards #puttingpatientsfirst #medicaloncologists #cancercarecontinuum #nextgenerationsequencing #comprehensivegenomicprofiling #guardant360 #guardantreveal #liquidbiopsy #guardant360tissuenext #tissuebiopsy

Message us